zigakibart
CFUB523A12201
Phase 2 mab active
Quick answer
zigakibart for Immunoglobulin A Nephropathy (IgAN) is a Phase 2 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Immunoglobulin A Nephropathy (IgAN)
- Phase
- Phase 2
- Modality
- mab
- Status
- active